55
Growth Score in past quarter
pts
Heat Score 55 in past quarter
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
685454
LysoTech is a drug development company that researches and develops biopharmaceutical drugs.
Acquired by 
Dalim Biotech
About the Company
LysoTech is a developer of drugs based on autophagy intended to treat diseases by improving the functions of cell organelles. LysoTech focused on treatments for diabetes, dementia, and non-alcoholic steatohepatitis through an autophagy control platform and lysosome activation, enabling patients to get better health and quality of life.